Efficacy and Safety Evaluation of Pegamotecan (PEG-camptothecin) in Advanced or Metastatic Soft Tissue Sarcoma
NCT00079950 · Status: SUSPENDED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2012-09-06
Summary
The purpose of this study is to evaluate the safety and efficacy of Pegamotecan (Peg-Camptothecin) in patients with Advanced or Metastatic Soft Tissue sarcoma.
Conditions
- Sarcoma, Soft Tissue
Interventions
- DRUG
-
Pegamotecan
Sponsors & Collaborators
-
Enzon Pharmaceuticals, Inc.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-08-31
Countries
- United States
Study Locations
More Related Trials
-
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
NCT05755113 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
NCT05557045 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
NCT03056001 ·Status: COMPLETED ·Phase: PHASE2
-
TVEC and Preop Radiation for Sarcoma (4 ml Dose)
NCT02453191 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
NCT00107419 ·Status: COMPLETED ·Phase: PHASE2
-
Doxorubicin With or Without Ifosfamide and Pegfilgrastim in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00061984 ·Status: COMPLETED ·Phase: PHASE3
-
YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
NCT05448820 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery
NCT01623869 ·Status: COMPLETED ·Phase: PHASE2
-
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
NCT00976508 ·Status: TERMINATED ·Phase: PHASE1
-
Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy
NCT01710176 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
NCT01782313 ·Status: COMPLETED ·Phase: PHASE2
-
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360 ·Status: COMPLETED ·Phase: PHASE2
-
Troglitazone in Treating Patients With Liposarcoma
NCT00003058 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors
NCT00560235 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of XmAb23104 in People With Sarcoma
NCT05879185 ·Status: TERMINATED ·Phase: PHASE2
-
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue Sarcoma
NCT04200443 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CP4071 in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00017446 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase 3 Study to Treat Patients With Soft Tissue Sarcomas
NCT02049905 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma
NCT00000763 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of GPX-150 to Treat Soft Tissue Sarcoma
NCT02267083 ·Status: COMPLETED ·Phase: PHASE2
-
sEphB4-HSA in Treating Patients With Kaposi Sarcoma
NCT02799485 ·Status: COMPLETED ·Phase: PHASE2
-
Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma
NCT00077285 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral Tomivosertib (eFT-508) in Subjects With Hematological Malignancies
NCT02937675 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma
NCT04173338 ·Status: TERMINATED ·Phase: PHASE1
-
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
NCT06660810 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2